Topics

"Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis" Drugs and Medication Database

18:19 EST 20th January 2020 | BioPortfolio

Here are the most relevant "Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis" Drugs and Medications that we have found in our database.

More Information about "Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis" on BioPortfolio

We have published hundreds of Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis news stories on BioPortfolio along with dozens of Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis Clinical Trials and PubMed Articles about Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis Companies in our database. You can also find out about relevant Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis Drugs and Medications on this site too.

Showing "Minnesota Adds Chronic Pain Macular Degeneration Medical Cannabis" Drugs and Medications 1–25 of 30

Possibly Relevant

Macugen [bausch & lomb incorporated]

These highlights do not include all the information needed to use MACUGEN safely and effectively. See full prescribing information for MACUGEN. MACUGEN(pegaptanib sodium injection)Intravitreal InjectionInitial U.S. Approval: 2004

Visudyne [qlt ophthalmics, inc.]

VISUDYNE (VERTEPORFIN FOR INJECTION)

Jetrea [thrombogenics inc.]

These highlights do not include all the information needed to use JETREA safely and effectively. See full prescribing information for JETREA JETREA (ocriplasmin) injection, for intravitreal injectionInitial U.S. Approval: 2012

Lucentis [genentech, inc.]

These highlights do not include all the information needed to use LUCENTIS safely and effectively. See full prescribing information for LUCENTIS. LUCENTIS (ranibizumab injection) for intravitreal injection Initial U.S. Approval: 2006

Cesamet [meda pharmaceuticals inc.]

NA

Plaquenil [avkare, inc.]

Plaquenil hydroxychloroquine sulfate tablets, USP

Hydroxychloroquine sulfate [aphena pharma solutions - tennessee, llc]

HYDROXYCHLOROQUINE SULFATE TABLETS, USP

Latanoprost [rebel distributors corp]

Latanoprost Ophthalmic Solution 0.005% (50 ug/mL)

Xalatan [dispensing solutions, inc.]

Xalatan latanoprost ophthalmic solution0.005% (50 µg/mL)

Latanoprost [physicians total care, inc.]

Latanoprost Ophthalmic Solution 0.005% (50 ug/mL)

Latanoprost [direct rx]

LATANOPROST

Plaquenil [carilion materials management]

PLAQUENIL® HYDROXYCHLOROQUINE SULFATE, USP

Clonidine hydrochloride [h. j. harkins company inc.]

NA

Visudyne [valeant pharmaceuticals north america llc]

These highlights do not include all the information needed to use VISUDYNE® safely and effectively. See full prescribing information for VISUDYNE®.VISUDYNE® (verteporfin for injection), for intravenous useInitial U.S. Approval: 2000

Ozurdex [allergan, inc.]

These highlights do not include all the information needed to use OZURDEX® safely and effectively. See full prescribing information for OZURDEX . OZURDEX (dexamethasone intravitreal implant) For Intravitreal Injection Initial U.S. Approval: 1958

Plaquenil [aphena pharma solutions - tennessee, llc]

PLAQUENIL®HYDROXYCHLOROQUINE SULFATE, USP

Chloroquine phosphate [ranbaxy pharmaceuticals inc.]

NA

Latanoprost [sandoz inc]

These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION.LATANOPROST ophthalmic solution 0.005%Initial U.S. Approval: 199

Dronabinol [akorn, inc.]

These highlights do not include all the information needed to use DRONABINOL CAPSULES safely and effectively. See full prescribing information for DRONABINOL CAPSULES.DRONABINOL capsules, for oral use, CIII Initial U.S. Approval: 1985

Chloroquine phosphate [pd-rx pharmaceuticals, inc.]

NA

Latanoprost [american regent, inc.]

These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1

Chloroquine phosphate [ranbaxy pharmaceuticals inc. ]

NA

Latanoprost [a-s medication solutions]

These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION.LATANOPROST ophthalmic solution, 0.005%Initial U.S. Approval: 19

Travoprost ophthalmic solution 0.004% [par pharmaceutical, inc.]

These highlights do not include all the information needed to use Travoprost Ophthalmic Solution USP, 0.004% safely and effectively. See full prescribing information for Travoprost Ophthalmic Solution USP, 0.004%.Initial U.S. Approval: 2001

Latanoprost [nucare pharmaceuticals,inc.]

These highlights do not include all the information needed to use LATANOPROST OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROST OPHTHALMIC SOLUTION. LATANOPROST ophthalmic solution 0.005% Initial U.S. Approval: 1



Quick Search